A reliable cell-based assay for testing unclassified TSC2 gene variants
Authors:
- 15 October 2008
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 17 (3) , 301-310
Abstract
Tuberous sclerosis complex (TSC) is characterised by seizures, mental retardation and the development of hamartomas in a variety of organs and tissues. The disease is caused by mutations in either the TSC1 gene or the TSC2 gene. The TSC1 and TSC2 gene products, TSC1 and TSC2, form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR). We have developed a straightforward, semiautomated in-cell western (ICW) assay to investigate the effects of amino acid changes on the TSC1–TSC2-dependent inhibition of mTOR activity. Using this assay, we have characterised 20 TSC2 variants identified in individuals with TSC or suspected of having the disease. In 12 cases, we concluded that the identified variant was pathogenic. The ICW is a rapid, reproducible assay, which can be applied to the characterisation of the effects of novel TSC2 variants on the activity of the TSC1–TSC2 complex.Keywords
This publication has 22 references indexed in Scilit:
- Functional characterisation of the TSC1–TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complexBMC Medical Genetics, 2008
- Unusually mild tuberous sclerosis phenotype is associated withTSC2R905Q mutationAnnals of Neurology, 2006
- A Novel Cell-Based Assay for G-Protein-Coupled Receptor–Mediated Cyclic Adenosine Monophosphate Response Element Binding Protein PhosphorylationSLAS Discovery, 2006
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- Distinct effects of single amino-acid changes to tuberin on the function of the tuberin–hamartin complexEuropean Journal of Human Genetics, 2004
- Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP ActivityMolecular and Cellular Biology, 2004
- Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosisJournal of Medical Genetics, 2004
- TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complexHuman Molecular Genetics, 2001
- Comprehensive Mutation Analysis of TSC1 and TSC2—and Phenotypic Correlations in 150 Families with Tuberous SclerosisThe American Journal of Human Genetics, 1999
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993